Advertisement
Screener

Zoetis Inc. (ZTS) Price / FCF

Zoetis Inc. Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • Zoetis Inc. price-fcf ratio for the quarter ending 2026-06-30 was 12.85, a 57.87% decline year-over-year.
  • Zoetis Inc. price-fcf ratio for the quarter ending 2026-03-31 was 22.21, a 34.08% decline year-over-year.
  • Zoetis Inc. price-fcf ratio for the quarter ending 2025-12-31 was 23.42, a 26.35% decline year-over-year.
  • Zoetis Inc. price-fcf ratio for the quarter ending 2025-09-30 was 28.85, a 24.52% decline year-over-year.
  • Zoetis Inc. price-fcf ratio for fiscal 2026 was 12.85.
  • Zoetis Inc. price-fcf ratio for fiscal 2025 was 23.42, a 26.35% decline from fiscal 2024.
  • Zoetis Inc. price-fcf ratio for fiscal 2024 was 31.8, a 43.03% decline from fiscal 2023.
  • Zoetis Inc. price-fcf ratio for fiscal 2023 was 55.81, a 8.88% increase from fiscal 2022.
Available history
2013-06-30 to 2026-06-30
Data captured

Historical Price-FCF Ratio

DatePrice-FCF RatioMarket capitalizationFree cash flow 12 monthFree cash flow 3 month
2026-06-3012.85$29.76B$2.32B$538.00M
2026-03-3122.21$49.68B$2.24B$291.00M
2025-12-3123.42$53.46B$2.28B$732.00M
2025-09-3028.85$64.63B$2.24B$755.00M
2025-06-3030.5$69.22B$2.27B$459.00M
2025-03-3133.69$73.44B$2.18B$337.00M
2024-12-3131.8$73.07B$2.3B$689.00M
2024-09-3038.23$88.22B$2.31B$784.00M
2024-06-3037.41$78.67B$2.1B$370.00M
2024-03-3144.18$77.32B$1.75B$455.00M
2023-12-3155.81$90.47B$1.62B$699.00M
2023-09-3053.58$79.95B$1.49B$579.00M
2023-06-3061.75$79.35B$1.29B$17.00M
2023-03-3152.8$76.98B$1.46B$326.00M
2022-12-3151.26$67.97B$1.33B$570.00M
2022-09-3054.59$69.17B$1.27B$372.00M
2022-06-3056.37$80.55B$1.43B$190.00M
2022-03-3155.3$88.87B$1.61B$194.00M
2021-12-3166.43$115.32B$1.74B$511.00M
2021-09-3051.31$91.9B$1.79B$534.00M
2021-06-3051.92$88.37B$1.7B$368.00M
2021-03-3144.47$74.8B$1.68B$323.00M
2020-12-3147.02$78.67B$1.67B$566.00M
2020-09-3051.6$78.59B$1.52B$445.00M
2020-06-3044.71$65.09B$1.46B$348.00M
2020-03-3142.24$55.89B$1.32B$314.00M
2019-12-3147.14$62.94B$1.34B$416.00M
2019-09-3043.51$59.4B$1.37B$378.00M
2019-06-3037.07$54.23B$1.46B$215.00M
2019-03-3133.44$48.22B$1.44B$326.00M
2018-12-3128.25$41.02B$1.45B$446.00M
2018-09-3028.76$44.04B$1.53B$476.00M
2018-06-3028.41$41.09B$1.45B$194.00M
2018-03-3129.31$40.48B$1.38B$336.00M
2017-12-3131.21$35.02B$1.12B$525.00M
2017-10-0137.79$31.1B$823M$391.00M
2017-07-0249.75$30.54B$614M$129.00M
2017-04-0246.17$26.22B$568M$77.00M
2016-12-3153.08$26.38B$497M$226.00M
2016-10-0254.93$25.71B$468M$182.00M
2016-07-0353.67$23.51B$438M$83.00M
2016-04-0351.82$22.33B$431M$6.00M
2015-12-3154.17$23.84B$440M$197.00M
2015-09-2736.59$21.18B$579M$152.00M
2015-06-2849.75$24.28B$488M$76.00M
2015-03-2943.72$23.13B$529M$15.00M
2014-12-3148.37$21.57B$446M$336.00M
2014-09-2851.14$18.36B$359M$61.00M
2014-06-2945.44$16.22B$357M$117.00M
2014-03-3085.45$14.53B$170M-$68.00M
2013-12-3132.89$16.35B$497M$249.00M
2013-09-2930.36$15.58B$513M$59.00M
2013-06-3030.77$15.44B$502M-$70.00M

Annual Price-FCF Ratio

DatePrice-FCF RatioMarket capitalizationFree cash flow 12 monthFree cash flow 3 month
2026-06-3012.85$29.76B$2.32B$538.00M
2025-12-3123.42$53.46B$2.28B$732.00M
2024-12-3131.8$73.07B$2.3B$689.00M
2023-12-3155.81$90.47B$1.62B$699.00M
2022-12-3151.26$67.97B$1.33B$570.00M
2021-12-3166.43$115.32B$1.74B$511.00M
2020-12-3147.02$78.67B$1.67B$566.00M
2019-12-3147.14$62.94B$1.34B$416.00M
2018-12-3128.25$41.02B$1.45B$446.00M
2017-12-3131.21$35.02B$1.12B$525.00M
2016-12-3153.08$26.38B$497M$226.00M
2015-12-3154.17$23.84B$440M$197.00M
2014-12-3148.37$21.57B$446M$336.00M
2013-12-3132.89$16.35B$497M$249.00M

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10